Imipenem: a new carbapenem antibiotic
- PMID: 3280907
- DOI: 10.1016/s0025-7125(16)30759-3
Imipenem: a new carbapenem antibiotic
Abstract
Imipenem is a new carbapenem antibiotic that has an extremely broad spectrum of antibacterial activity. It has been used to treat a variety of serious infections and an increasing volume of literature documents its value in infections due to multiresistant bacteria. This article reviews the antibacterial activity, pharmacology, and clinical uses of imipenem.
Similar articles
-
Imipenem-cilastatin: the first thienamycin antibiotic.Pediatr Infect Dis. 1986 Jul-Aug;5(4):444-8. Pediatr Infect Dis. 1986. PMID: 3523460 Review. No abstract available.
-
Pharmacokinetic and clinical evaluation of imipenem/cilastatin in children and neonates.Scand J Infect Dis Suppl. 1987;52:40-5. Scand J Infect Dis Suppl. 1987. PMID: 3483288
-
Imipenem/cilastatin: the first carbapenem antibiotic.Drug Intell Clin Pharm. 1985 Dec;19(12):895-9. Drug Intell Clin Pharm. 1985. PMID: 3910385 Review.
-
Primaxin: an antibiotic for (nearly) all bacterial infections.Nursing. 1987 Mar;17(3):102. doi: 10.1097/00152193-198703000-00033. Nursing. 1987. PMID: 3644166 No abstract available.
-
Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.Arch Surg. 1988 Mar;123(3):322-6. doi: 10.1001/archsurg.1988.01400270056008. Arch Surg. 1988. PMID: 3277587 Clinical Trial.
Cited by
-
Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats.Antimicrob Agents Chemother. 1993 Feb;37(2):199-202. doi: 10.1128/AAC.37.2.199. Antimicrob Agents Chemother. 1993. PMID: 8383938 Free PMC article.
-
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.Antimicrob Agents Chemother. 1989 Jul;33(7):1009-18. doi: 10.1128/AAC.33.7.1009. Antimicrob Agents Chemother. 1989. PMID: 2789493 Free PMC article.
-
Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens.Front Microbiol. 2017 May 8;8:805. doi: 10.3389/fmicb.2017.00805. eCollection 2017. Front Microbiol. 2017. PMID: 28533769 Free PMC article.
-
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.Antimicrob Agents Chemother. 1991 Jan;35(1):203-7. doi: 10.1128/AAC.35.1.203. Antimicrob Agents Chemother. 1991. PMID: 1901698 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical